RCT: Can a Single Counseling Phone Call Improve Contraception After an Abortion?
PPR
A Randomized Controlled Trial: Contraceptive Counseling After an Abortion
1 other identifier
interventional
207
1 country
1
Brief Summary
Hypothesis: Use of an effective contraceptive six weeks after abortion will be higher in the treatment group than in the control group. Primary Aim ·To determine use of an effective contraceptive method six weeks after abortion in women who choose combined hormonal contraception (CHC) and who receive a three-week educational phone call as compared to women who do not receive the intervention. Secondary Aims
- To describe the most common concerns and logistical problems women experience with initiating and adhering to CHC after abortion.
- To describe the concerns that lead to discontinuation or method change. \*To assess feasibility of conducting a follow-up telephone call in this population This is a randomized, controlled trial to assess the effect of a three-week follow-up phone call in women who choose combined hormonal contraception on the day of their abortion at the San Francisco General Hospital Women's Options Center. Subjects randomized to the treatment group will receive an interventional phone call three weeks after their abortion; participants randomized to the control group will not receive the call. All subjects will receive a follow-up call six weeks after their abortion to assess and compare method use between the two groups. Calls will be made at three- and six-weeks post abortion in order to give subjects enough time to initiate CHC and to assess continuation into the second month of the method. Data will be collected at baseline, during the intervention for the treatment group and during the final follow-up call for both groups. The primary outcome is use of an effective contraceptive six weeks after abortion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2010
CompletedFirst Posted
Study publicly available on registry
September 13, 2010
CompletedStudy Start
First participant enrolled
March 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedResults Posted
Study results publicly available
September 19, 2019
CompletedSeptember 19, 2019
August 1, 2019
1.8 years
September 9, 2010
March 5, 2019
August 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Using an Effective Contraceptive Method 6 Weeks After Abortion
To determine use of an effective contraceptive method six weeks after abortion in women who choose combined hormonal contraception (CHC) and who receive a three-week educational phone call as compared to women who do not receive the intervention.
6 weeks after abortion procedure
Secondary Outcomes (1)
Reasons for Discontinuation of Contraception
6 weeks after abortion procedure
Study Arms (2)
Control
NO INTERVENTIONThe control group will not receive a counseling phone call one month after enrollment.
Intervention
EXPERIMENTALIntervention arm receives a counseling phone call 3 to 4 weeks after enrollment. The call is from a health educator intended to assist with contraception.
Interventions
Subjects in the treatment arm will receive a phone call from a health educator to assist with contraception, 3 to 4 weeks after enrollment.
Eligibility Criteria
You may qualify if:
- Women over the age of 15 who choose pill, patch or ring to begin after their abortion
- Women able and willing to be contacted by phone for up to 2 months after enrollment
You may not qualify if:
- Women who do not speak and read English or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Francisco General Hospital
San Francisco, California, 94110, United States
Results Point of Contact
- Title
- Director for Research Operations
- Organization
- University of California, San Francisco
Study Officials
- PRINCIPAL INVESTIGATOR
Jody Steinauer, MD, MAS
University of California, San Francisco
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2010
First Posted
September 13, 2010
Study Start
March 21, 2011
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
September 19, 2019
Results First Posted
September 19, 2019
Record last verified: 2019-08